{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:42:26Z","timestamp":1787773346258,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Non-alcoholic fatty liver disease (NAFLD) and Type 2 diabetes mellitus (T2DM) often coexist and drive detrimental effects in a synergistic manner. This study was designed to understand the changes in circulating lipid and lipoprotein metabolism in patients with T2DM with or without NAFLD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Four hundred thirty-four T2DM patients aged 18\u201360\u00a0years were included in this study. Fatty liver was assessed by FibroScan. The comprehensive metabolic lipid profiling of serum samples was assessed by using high-throughput proton NMR metabolomics.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our data revealed a significant association between steatosis and serum total lipids in VLDL and LDL lipoprotein subclasses, while total lipids in HDL subclasses were negatively associated. A significant positive association was found between steatosis and concentration of lipids, phospholipids, cholesterol, and triglycerides in VLDL and LDL subclasses, while HDL subclasses were negatively associated. Furthermore, a significant, association was observed between fibrosis and concentrations of lipids, phospholipids, cholesterol, and triglycerides in very small VLDL, large, and very large HDL subclasses. Subgroup analysis revealed a decrease in the concentrations of lipids, phospholipids, cholesterol, and other lipid biomolecules in patients using antilipemic medications.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The metabolomics results provide evidence that patients with T2DM with higher steatosis grades have altered lipid metabolomics compared to patients without steatosis. Increased lipid, phospholipids, cholesterol, and triglycerides concentration of VLDL and LDL subclasses are associated with steatosis in patients with T2DM.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1030661","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T11:00:07Z","timestamp":1677236407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Assim A.","family":"Alfadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman M.","family":"Almaghamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphia Murad","family":"Sherbeeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel N.","family":"Alqutub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Aldosary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C.","family":"Isnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Taylor-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2468-1253(19)30419-4","article-title":"Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study","volume":"5","author":"Abeysekera","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/sjg.sjg_73_22","article-title":"Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study","volume":"28","author":"Alfadda","year":"2022","journal-title":"Saudi J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J. Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3945\/ajcn.111.030114","article-title":"Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial","volume":"95","author":"Bjermo","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00125480-200201000-00005","article-title":"The clinicopathologic spectrum and management of nonalcoholic fatty liver disease","volume":"9","author":"Contos","year":"2002","journal-title":"Adv. Anat. Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"Qjm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"J. Clin. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/liv.13076","article-title":"Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease","volume":"36","author":"Jiang","year":"2016","journal-title":"Liver Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.28899","article-title":"Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study","volume":"65","author":"Kaikkonen","year":"2017","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2012-303179","article-title":"Molecular interplay between \u03945\/\u03946 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis","volume":"63","author":"L\u00f3pez-Vicario","year":"2014","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.clnu.2011.12.007","article-title":"Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes","volume":"31","author":"Petit","year":"2012","journal-title":"Clin. Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3748\/wjg.v22.i4.1664","article-title":"Mechanisms of intrahepatic triglyceride accumulation","volume":"22","author":"Ress","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db13-1622","article-title":"Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans","volume":"63","author":"Rosqvist","year":"2014","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ. Cardiovasc Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1878-5085-5-21","article-title":"4Ps medicine of the fatty liver: The research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics","volume":"5","author":"Trovato","year":"2014","journal-title":"Epma J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.metabol.2016.01.011","article-title":"Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity","volume":"65","author":"Walle","year":"2016","journal-title":"Metabolism"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ceh.2021.104441","article-title":"Non-alcoholic fatty liver disease and lipotoxicity","volume":"7","author":"Wasilewska","year":"2021","journal-title":"Clin. Exp. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"W\u00fcrtz","year":"2015","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11745-012-3671-4","article-title":"Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China","volume":"47","author":"Zheng","year":"2012","journal-title":"Lipids"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1030661\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T11:00:09Z","timestamp":1677236409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1030661\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":32,"alternative-id":["10.3389\/fmolb.2023.1030661"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1030661","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"article-number":"1030661"}}